L

Ligand Pharmaceuticals
D

LGND

294.92
USD
-8.71
(-2.87%)
مغلق
حجم التداول
7,566
الربح لكل سهم
9
العائد الربحي
-
P/E
30
حجم السوق
5,879,409,806
أصول ذات صلة

العنوان: Ligand Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.